Novel use of hepatobiliary scintigraphy for the diagnosis of interleukin-2 cholangiopathy

Hellenic Journal of Nuclear Medicine

Volumn 13, Issue 2, 2010, Pages 163-165

  Marti, Jon K ^a   Banks, Kevin P ^b   Song, Won S ^c  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b BROOKE ARMY MEDICAL CENTER   (United States)

^c NONE

Author keywords

Acalculous cholecystitis; Cholangiopathy; Hepatobiliary scintigraphy; Interleukin 2

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; INTERLEUKIN 2;

ACALCULOUS CHOLECYSTITIS; ADULT; ARTICLE; CASE REPORT; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; EDEMA; HEPATOBILIARY SCINTISCANNING; HOSPITAL ADMISSION; HUMAN; LIVER FUNCTION TEST; LUNG DISEASE; LUNG METASTASIS; MALE; MELANOMA; METASTASIS; PHYSICAL EXAMINATION; REMISSION; THORAX PAIN;

ADULT; BILE DUCT DISEASES; BILIARY TRACT; HUMANS; INTERLEUKIN-2; LIVER; MALE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956359723     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. van Brieda Vriesman AC, Engelbrecht MR, Smithuis RH, Puylaert JB. Diffuse Gallbladder Wall Thickening: Differential Diagnosis. AJR 2007; 188: 495-501. (Pubitemid 46167752)
2. Premkumar AH, Walworth CM, Vogel S et al. Prospective Sonographic Evaluation of Interleukin-2-induced Changes in the Gallbladder. Radiology 1998; 206: 393-6.
3. Powell FC, Spooner KM, Shawker TH et al. Symptomatic interleukin-2 induced cholecystopathy in patients with HIV infection. AJR 1994; 163: 117-21.
4. Rosenberg SA, Lotze MT, Muul LM et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine activated killer cells and interleukin-2 or high dose interleukin-2 alone. N Engl J Med 1987; 316: 889-905.
5. Rosenberg SA. Interleukin 2 for patients with renal cancer. Nat Clin Pract Oncol 2007; 4: 497.
6. Schwinger W, Klass V, Benesch M et al. Feasibility of high-dose interleukin-2 in heavily pretreated pediatric cancer patients. Ann of Oncol 2005; 16: 1199-206.
7. Lissoni P, Barni S, Cattaneo G et al. Activation of the complement system during immunotherapy of cancer with interleukin-2: a possible explanation of the capillary leak syndrome. Int J Biol Markers 1990; 5: 195-207.